 Author information
11] Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. [2] Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. [3] Cancer Institute, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
2Nature Medicine, New York, New York, USA.
31] Department of Oncology, University of Torino, Candiolo, Torino, Italy. [2] Candiolo Cancer Institute-Fondazione del Piemonte per l'Oncologia (FPO), IRCCS, Candiolo, Torino, Italy.
4Université Libre de Bruxelles (ULB), Brussels, Belgium.
51] CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. [2] Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
6Nature Medicine, New York, New York, USA.
7Department of Oncology, University of Cambridge, Cambridge, UK.
81] Department of Systems Biology, Columbia University, New York, New York, USA. [2] Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York, USA. [3] Department of Biomedical Informatics, Columbia University, New York, New York, USA.
9Genentech Inc., South San Francisco, California, USA.
10Nature Biotechnology, New York, New York, USA.
11Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, Barcelona, Catalonia, Spain.
12MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, UK.
13Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
14German Cancer Research Center, DKFZ, Heidelberg, Germany.
15Weill Cornell Medical College, New York, New York, USA.
161] Department of Genetics, MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, Texas, USA.
171] Department of Systems Biology, Columbia University, New York, New York, USA. [2] Department of Biological Sciences, Columbia University, New York, New York, USA.
18Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
19Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
20Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
21Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
22Nature Medicine, New York, New York, USA.
231] University College London Cancer Institute, London, UK. [2] University College London Hospitals NHS Foundation Trust, London, UK. [3] The Francis Crick Institute, London, UK.
241] Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
25The Cancer Genome Atlas, Center for Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
26Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
27Inserm, UMR-1162, Génomique fonctionnelle des tumeurs solides, Institut Universitaire d'Hématologie (IUH), Paris, France.
|